ExecSalaries→Healthcare→ROIV
Home · Healthcare · ROIV

Roivant Sciences Executive Compensation

ROIV · Healthcare · FY2024 Data

Roivant Sciences is a publicly traded company in the Healthcare sector.

Total Exec Pay FY2024
$438.2M
Highest Paid Executive
$251.9M
Executives Tracked
6
💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Data available:FY2024FY2023

Named Executive Officers — FY2024

ExecutiveYearBaseStockTotal Pay
Mayukh Sukhatme
President and Chief Investment Officer
FY2024$550,000$170.2M$251.9M
Matthew Gline
Chief Executive Officer
FY2024$725,000$157.6M$163.3M
Eric Venker
President and Immunovant CEO
FY2024$600,208$5.1M$11.8M
Rakhi Kumar
Chief Accounting Officer
FY2024$370,156$2.3M$4.7M
Richard Pulik
Chief Financial Officer
FY2024$437,750$2.6M$4.1M
Jennifer Humes
Chief Accounting Officer
FY2024$41,897$2.1M$2.4M

Compensation Analysis

Computed directly from SEC-sourced figures tracked on this page — not a general description.

Roivant Sciences discloses FY2024 compensation for 6 named executive officers, totaling $438.2M. Mayukh Sukhatme, the President and Chief Investment Officer, accounts for 57% of that combined total.

Cash compensation (salary plus bonus) made up 22% of Roivant Sciences's FY2024 tracked executive pay, with stock awards accounting for 78%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.

Among 78 other Healthcare companies in this dataset, Roivant Sciences's combined tracked executive pay of $438.2M ranks in the 100th percentile (industry median: $12.5M). Its highest-paid executive, Mayukh Sukhatme, ranks in the 100th percentile for top-executive pay in the sector (industry median: $6.0M).

Historical Compensation Data

ExecutiveYearBaseStockTotal
FY2024$550,000$170.2M$251.9M
FY2024$725,000$157.6M$163.3M
FY2024$600,208$5.1M$11.8M
FY2024$370,156$2.3M$4.7M
FY2024$437,750$2.6M$4.1M
FY2024$41,897$2.1M$2.4M
FY2023$425,000$2.9M$5.1M
FY2023$375,000$2.3M$4.3M
FY2023$725,000—$738,189
Data Source: Compensation figures are sourced from Roivant Sciences's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect the most recently available fiscal year per executive. See something wrong? Report it.
ROIV — Quick Facts
CompanyRoivant Sciences
TickerROIV
IndustryHealthcare
Most Recent DataFY2024
Years of Data2
Total Exec Pay$438.2M
Executives Tracked6
Browse Healthcare
View all Healthcare executives →
ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Corrections Policy · Privacy Policy